These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22190090)

  • 21. Sitting up and taking notice.
    Nat Biotechnol; 2010 May; 28(5):381. PubMed ID: 20458284
    [No Abstract]   [Full Text] [Related]  

  • 22. Introduction: Access to life-saving medicines and intellectual property rights.
    Schroeder D
    Camb Q Healthc Ethics; 2011 Apr; 20(2):277-8. PubMed ID: 21435302
    [No Abstract]   [Full Text] [Related]  

  • 23. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
    Tear S; Zarkowska T
    IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
    [No Abstract]   [Full Text] [Related]  

  • 24. Patent laws. Report urges leeway for developing world.
    Couzin J; Bagla P
    Science; 2002 Sep; 297(5588):1791. PubMed ID: 12228696
    [No Abstract]   [Full Text] [Related]  

  • 25. Big companies helped by safe harbour ruling.
    Frantz S
    Nat Rev Drug Discov; 2005 Jul; 4(7):525-6. PubMed ID: 16075481
    [No Abstract]   [Full Text] [Related]  

  • 26. UN steps up action on traditional knowledge.
    Kapp C
    Lancet; 2003 Oct; 362(9391):1206. PubMed ID: 14570035
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand.
    Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P
    Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asian medicine. The new face of traditional Chinese medicine.
    Normile D
    Science; 2003 Jan; 299(5604):188-90. PubMed ID: 12522228
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intellectual property rights and right of access to medicines].
    Velásquez G
    Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staving off death: a case study of the pharmaceutical industry's strategies to protect blockbuster franchises.
    Gorlin DI
    Food Drug Law J; 2008; 63(4):823-64. PubMed ID: 19601385
    [No Abstract]   [Full Text] [Related]  

  • 31. Incentive to be inventive.
    Nat Rev Drug Discov; 2005 Jul; 4(7):523. PubMed ID: 16060056
    [No Abstract]   [Full Text] [Related]  

  • 32. Science and the law. Working through the patent problem.
    Walsh JP; Cohen WM; Arora A
    Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
    [No Abstract]   [Full Text] [Related]  

  • 33. Increasing contribution of China in modern biomedical research. Statistical data from ISI Web of Knowledge.
    Makris GC; Spanos A; Rafailidis PI; Falagas ME
    Med Sci Monit; 2009 Dec; 15(12):SR15-21. PubMed ID: 19946247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the pharmaceutical sector have a coresponsibility for the human right to health?
    Schroeder D
    Camb Q Healthc Ethics; 2011 Apr; 20(2):298-308. PubMed ID: 21435305
    [No Abstract]   [Full Text] [Related]  

  • 35. Review and challenges of policies of environmental protection and sustainable development in China.
    Zhang KM; Wen ZG
    J Environ Manage; 2008 Sep; 88(4):1249-61. PubMed ID: 17767999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Access to life-saving medicines and intellectual property rights: an ethical assessment.
    Schroeder D; Singer P
    Camb Q Healthc Ethics; 2011 Apr; 20(2):279-89. PubMed ID: 21435303
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evolution, characteristics and enlightenment of self-innovation of traditional Chinese medicine industry].
    Feng ZP; Tao QS; Peng DY; Wei H
    Zhongguo Zhong Yao Za Zhi; 2015 Jun; 40(11):2252-7. PubMed ID: 26552191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 39. Biotech in post-TRIPS India.
    Ramani SV; Pradhan P; Ravi M
    Nat Biotechnol; 2005 Jan; 23(1):18-9. PubMed ID: 15637608
    [No Abstract]   [Full Text] [Related]  

  • 40. Health priorities gain patent reprieve for developing countries.
    Cherry M
    Nature; 2001 Nov; 414(6862):385. PubMed ID: 11719767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.